Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/q/burkitt/) was not found.

Search q burkitt at Google

Search q burkitt at Yahoo

Search q burkitt at Msn

Google
 
(Date:10/15/2008)...main separate are crucial questions in evolutionar...ent animal species are often infertile or die when...produce. A sheep-goat hybrid, the result of a cros.... Such hybrids can also be dysfunctional, for exam... sounds from both parent species. , Remarkably, ...
(Date:10/14/2008)...ecade, biomedical and research breakthroughs, nota...orm the care of children, improving diagnosis and ...Morgan Stanley Children,s Hospital of NewYork-Pres...ll host a conference at the Grand Hyatt New York, ...hange the latest advances in genetics, stem cell t...
(Date:10/14/2008)...ead of the Computational Neurobiology Laboratory a...tute of Medicine, the IOM has announced. Election ... in the fields of health and medicine and recogniz...rofessional achievement and commitment to service....istinguished and influential individuals to the In...
(Date:10/14/2008)... Coastal dead zones, an increasing concern to eco...not be as devoid of life after all. A Brown scient...rine life, and that at least one commercially valu...aters. , Andrew Altieri, a post-doctoral researc...Biology at Brown University, studied dead zones in...
Breaking Biology News(10 mins):Turtle doves commit adultery 2Turtle doves commit adultery 3Innovations in Pediatric Medicine CME conference brings together national pediatrics experts 2Innovations in Pediatric Medicine CME conference brings together national pediatrics experts 3Innovations in Pediatric Medicine CME conference brings together national pediatrics experts 4Salk researcher Terry Sejnowski elected to Institute of Medicine 2Brown scientist finds coastal dead zones may benefit some species 2Brown scientist finds coastal dead zones may benefit some species 3Onyx Pharmaceuticals Announces Management Changes 2852 1Onyx Pharmaceuticals Announces Management Changes 2852 2Onyx Pharmaceuticals Announces Management Changes 2852 3American Stock Exchange Accepts Encisions Plan to Regain Compliance 2848 1American Stock Exchange Accepts Encisions Plan to Regain Compliance 2848 2IDM Pharma to Present at BIO InvestorForum in San Francisco 1045 1IDM Pharma to Present at BIO InvestorForum in San Francisco 1045 2IDM Pharma to Present at BIO InvestorForum in San Francisco 1045 3Anesiva Initiates Phase 2 Trial with Adlea 28TM 29 for Pain Relief Following Total Hip Replacement Surgery 444 1Anesiva Initiates Phase 2 Trial with Adlea 28TM 29 for Pain Relief Following Total Hip Replacement Surgery 444 2Anesiva Initiates Phase 2 Trial with Adlea 28TM 29 for Pain Relief Following Total Hip Replacement Surgery 444 3Anesiva Initiates Phase 2 Trial with Adlea 28TM 29 for Pain Relief Following Total Hip Replacement Surgery 444 4Anesiva Initiates Phase 2 Trial with Adlea 28TM 29 for Pain Relief Following Total Hip Replacement Surgery 444 5
... as,inevitable and obvious as “going gray,?yet sci...use of this usually unwelcome transformation.,In a...l Science,researchers from Dana-Farber Cancer Ins...e found the cellular cause of graying hair while,i...e potentially deadly,skin cancer. , The,scientists...
... as,inevitable and obvious as “going gray,?yet sci...use of this usually unwelcome transformation.,In a...l Science,researchers from Dana-Farber Cancer Ins...e found the cellular cause of graying hair while,i...e potentially deadly,skin cancer. , The,scientists...
... as,inevitable and obvious as “going gray,?yet sci...use of this usually unwelcome transformation.,In a...l Science,researchers from Dana-Farber Cancer Ins...e found the cellular cause of graying hair while,i...e potentially deadly,skin cancer. , The,scientists...
...of Energy,s Brookhaven National Laboratory have ap...imaging to track the distribution of nutrients in ...ack. The research provides new insights on a long-...mental stress, and shows that radiotracer imaging .... , Done in collaboration with scientists from Tuf...
Other Biology News:Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones. 2Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones. 3Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery 2Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery 3Scientists discover the cellular roots of graying hair 2Scientists discover the cellular roots of graying hair 3Poplar trees redirect resources in response to simulated attack 2Poplar trees redirect resources in response to simulated attack 3
(Date:10/15/2008)...ll., Oct. 15 /PRNewswire/ -- Post-graduate educati...tes of veterinary schools in,America, according to...can,Veterinary Medical Association (AVMA)., In th...ew veterinarians,reported that they were going int... internships and 6 percent into residencies. These...
(Date:10/15/2008)...ct. 15 /PRNewswire-FirstCall/ -- CTG HealthCare So...technology (IT) consulting firm,and a business un...lutions,and services company, today announced that... of Epic Systems clinical implementations., CTGHS...tal with a large,pediatric research program to sup...
(Date:10/15/2008)...and LONDON, Oct. 15 /PRNewswire/ -- Thomson Reuter...mation for businesses and,professionals, announced...new solution designed to help pharmaceutical organ...relationships with key opinion leaders,(KOLs) and ...able to the,industry that allows users to rank lif...
(Date:10/14/2008)... Calif., Oct. 14 /PRNewswire-FirstCall/ -- In ligh...markets, Apex Bioventures,Acquisition Corp. (Amex:...tion company with healthcare industry expertise, a... held in trust. As of October 14, 2008,the assets...y, with,Continental Transfer & Trust Company as tr...
Breaking Medicine News(10 mins):Health News:Post-Graduate Veterinary Education - Residencies and Internships - Becoming Very Popular Among New Veterinarians 2Health News:CTG HealthCare Solutions Announces New EPIC Implementation Engagements 2Health News:CTG HealthCare Solutions Announces New EPIC Implementation Engagements 3Health News:Thomson Reuters Launches Thomson Pharma KOLexperts(R) to Help the Pharmaceutical Industry Objectively Identify, Verify and Rank Scientific Experts, Product Advocates, Clinical Investigators and Key Opinion Leaders 2Health News:Apex Bioventures Announces Trust Investment Details 2
...e the compulsory licensing (CL) provision in the P... to produce and stockpile Swiss drug maker Roche’s...obal threat against the most dreaded avian flu vir...nt to issue CL without receipt of an application f...
...rdiac output, oxygen consumption, and myocardial a...he influence of heart rate on myocardial oxygen te...n of flexible pO2 micro catheters to measure parti...ible to investigate the influence of heart rate on...
...lakraj Behad has revealed for the first time the A... were 48 AIDS patients and 343 HIV positive cases ...y thrives on tourism as it is in the lower Himalay...s Badrinath, Kedarnath and Rishikesh. The health M...
...pid and carbohydrate metabolism, and is known to i... The use of glucose by the peripheral tissues and ...tential impact on long-term complications. In dia...d fat is abnormal and an association between the p...
Other Medicine News:Health News:Influence Of Heart Rate On Myocardial Oxygen Tension 2Health News:Carnitine deficiency in children and adolescents with type 1 diabetes 2
Inquire
Eliminate aerosol contamination, which causes false priming reactions in PCR. Hydrophobic, nonwicking and self-sealing barrier. Only air can pass through these aerosol-resistant pipet tips, in contra
...esistant Tips offer a safe alternative to using po...ed for applications such as PCR(a), pipetting radi..., ART Tips are excellent for tissue culture, gel l...RT Tips prevent aerosol contaminants and liquids f...
Inquire
Medicine Products:
(Date:10/15/2008)...iness development flexibility, TSX Exchange Symbo... Resverlogix Corp.,("Resverlogix") (TSX:RVX) annou...approximately 60% of its remaining USD$17.3 millio... of Resverlogix stated, "The,economic environment ...s,around the globe. This action limits our dilutio...
(Date:10/15/2008)...ober 15 /-,Simbionix USA Corporation ...C round of growth capital financing led by River C... Early Stage Partners and other existing,sharehold...d as the,company,s investment bankers. The investm...y rapid growth of its medical simulation technolog...
(Date:10/15/2008)...all/ -- Cryo-Cell,International, Inc. (OTC Bulleti... largest and most established family cord blood ba... and nine months ended August 31,2008., Consolid...tely $4.5,million compared to approximately $4.6 m...reported a net loss in the third quarter 2008 of,a...
(Date:10/15/2008)... Targeting Chemokine Receptor CC...Calif., Oct. 15 /- ChemoCentryx, Inc....clinical trial of CCX025,the company,s fourth inv...ed compound that inhibits the chemokine receptor k...EN(TM) (CCX282-B; ChemoCentryx,s CCR9,antagonist c...
Breaking Biology Technology:Resverlogix Eliminates Sixty Percent of Remaining Debt 2Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth 2Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth 3Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 2Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 3Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 4Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 5Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 6ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development 2ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development 3ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development 4
...nto certain forms of cancer has focused on disease...od. As these studies progress, significant lines o...s induced by cancer but changes in the sugar molec...n the serum of pancreatic cancer patients, for ins... structures that could be implicated in the way ca...
... a facility in Reno, Nev., commercial printer Qua...ties to the west coast. , ,Quad, which offers prin... purchased Craftsman Press West, a privately held ...ributed magazines, catalogs, and retail inserts. C...e purchase will expedite distribution but not crea...
...st Phone UI Ever, in which I vented my frustratio...ular 8125. Since that column, most people running ...vices have been a little sheepish when they come t...f these folks have a much better grasp of UI than ...er, HTC . , ,In fact, Ive downloaded a number of ...
...erge Technologies, Inc. , ,The embattled medical ... Merge Healthcare, has announced that it received ...Pedlar, its interim co-president and co-CEO, and p... Pedlar,s departure as of the close of business on...e the company this year amid its continuing inabil...
Other Biology Technology:GenTel licenses next generation cancer research 2GenTel licenses next generation cancer research 3More women needed in interface design 2More women needed in interface design 3More women needed in interface design 4Pedlar the latest executive to leave Merge 2
(Date:10/14/2008)...y and efficacy outcomes for two thirds ...and WASHINGTON, Oct. 14 /- ...announced 12-month left main and,three-vessel dise...paring,percutaneous coronary intervention (PCI) us...oronary Stent System to contemporary coronary arte...
(Date:10/14/2008)...aratek Pharmaceuticals, Inc. today,announced the C...0796, a,first-in-class aminomethylcycline, will be... at the 48th Interscience Conference on Antimicrob... held in Washington, D.C.,from October 25 - Octobe...on at ICAAC:, Sunday, October 26, 12:15 - 1:15...
(Date:10/13/2008)...T III Data Confirms Patients Treated, with XIENCE ... Attack or a Repeat Procedure Compared t...ewswire-FirstCall/ -- Data from an independent,met...ndomized clinical,trials demonstrated that the XIE... continues to deliver clinically significant benef...
(Date:10/13/2008)...iple Cancer Populations Facilitates ...ct. 13 /- Rubicon Genomics, Inc. toda...plify DNA samples for The,Cancer Atlas Genome Proj...d standardize total genomic,DNA from 3,000 tissue ...n,GenomePlex(TM) Whole Genome Amplification techno...
Breaking Medicine Technology:SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery 2SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery 3SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery 4SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery 5Paratek to Present Clinical Data in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 2Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 2Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 3Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 4Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 5Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 2Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 3Top Spin Appoints Yaron Tal President and Chief Executive Officer Erez Golan TopSpin Medicals Founder and Current Chief Executive Officer Will Cont 1040 1Top Spin Appoints Yaron Tal President and Chief Executive Officer Erez Golan TopSpin Medicals Founder and Current Chief Executive Officer Will Cont 1040 2Top Spin Appoints Yaron Tal President and Chief Executive Officer Erez Golan TopSpin Medicals Founder and Current Chief Executive Officer Will Cont 1040 3Parents can Help Young Superheroes Battle Cavities on Halloween Night 2842 1Parents can Help Young Superheroes Battle Cavities on Halloween Night 2842 2Prime Therapeutics Announces URAC Accreditation 2840 1Prime Therapeutics Announces URAC Accreditation 2840 2EpiCept Corporation to Present at the 2007 BIO InvestorForum 2836 1EpiCept Corporation to Present at the 2007 BIO InvestorForum 2836 2EpiCept Corporation to Present at the 2007 BIO InvestorForum 2836 3
... Spain, June 15, 2007 /PRNewswire-FirstCall/ --,Br... regarding the,efficacy and safety of ORENCIA(R) (... investigational study in children with juvenile,i...te response to,one or more disease-modifying anti-...TX) or tumor necrosis factor (TNF) antagonists.,Th...
...om 741-patient Trial Show Those Treated with Lumir... Blood Pressure Compared,to Ibuprofen, EAST HANOVE...th,osteoarthritis who also have controlled hyperte...ly blood pressure when treated with,the investigat...ed,to a slight increase in those taking ibuprofen,...
Other Medicine Technology:Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 2Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 3Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 4Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 5Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 6Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 2Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 3Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 4Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 5